Gitnux/Report 2026

Vo2 Max Testing Industry Statistics

The global cardiopulmonary exercise testing market is estimated at $1.63 billion in 2026, explore the figures behind company systems, pricing variation, and trend shifts through 2031.
3Statistics
24Sources
1Sections
1Visuals
11mRead
Vo2 Max Testing Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The vo2 max testing industry at a glance

The global cardiopulmonary exercise testing market, the closest measurable proxy for VO₂ max testing, is estimated at $1.63 billion in 2026 and is forecast to reach $2.71 billion by 2031.

$1.63B[4]
Global market size, 2026
10.74%[4]
Forecast CAGR, 2026–2031
38.46%[4]
North America share, 2025
53.41%[4]
Hospital end-user share, 2025
Market size
The global cardiopulmonary exercise testing market was valued at $1.47 billion in 2025 and is estimated at $1.63 billion in 2026. A narrower metabolic-testing-equipment definition places the 2025 market at $499.0 million, illustrating how results vary with the inclusion of clinical CPET systems and services.[4][5]
Forecast & CAGR
The global cardiopulmonary exercise testing market is projected to reach $2.71 billion by 2031, implying a 10.74% CAGR from 2026 to 2031. The narrower metabolic testing equipment market is forecast to grow from $533.9 million in 2026 to $981.6 million in 2035, at a 7.0% CAGR.[4][5]
Market share & regions
North America was the largest regional market in 2025, accounting for 38.46% of global cardiopulmonary exercise testing revenue. Asia-Pacific was identified as the fastest-growing region, with a forecast CAGR of 14.62% through 2031.[4]
Segmentation
CPET systems held 42.37% of product revenue in 2025, while clinical diagnostics represented 43.68% of application revenue. Hospitals accounted for 53.41% of end-user revenue, and cardiovascular diseases represented 34.52% of indication revenue.[4]
Key players & concentration
The market is characterized as having medium concentration. Reported leading manufacturers and brands include COSMED, Vyaire, MGC Diagnostics, CORTEX, Schiller, GE HealthCare, Philips and Nihon Kohden; a precise CR3, CR5 or HHI figure was not publicly disclosed in the available source.[4][6]
Pricing
In U.S. consumer and performance settings, a single VO₂ max test commonly costs about $100 to $250, depending on the facility and included analysis. UCSF lists its VO₂ max assessment at $299, while its test includes gas-exchange measurement and personalized training-zone information.[7][3]
Trends, drivers & challenges
Growth is being supported by demand for objective exercise-capacity assessment, cardiovascular and pulmonary disease management, pulmonary rehabilitation and sports-performance testing. Adoption remains constrained by equipment and service costs, specialist training requirements and inconsistent reimbursement; specialty cardiology and pulmonology clinics are forecast to grow at 13.28% annually through 2031.[4][8]
Consumer behavior & competition
The consumer market is expanding beyond hospitals into universities, performance centers, gyms and longevity providers, with tests sold directly for training-zone and fitness assessment purposes. Consumer-facing prices vary materially: Quest lists VO₂ max testing from $145, while UCSF lists a $299 assessment; smartwatch-based estimates compete with laboratory gas-analysis tests but do not provide the same direct measurement of oxygen uptake.[9][3]
Regulation
In the United States, clinical CPET is commonly billed under CPT 94621, which covers cardiopulmonary exercise testing with minute ventilation, carbon-dioxide production, oxygen uptake and electrocardiographic recordings. FDA-cleared metabolic systems include COSMED devices such as the K5 wearable metabolic technology, indicated for professional healthcare, rehabilitation and sports-medicine settings.[8][10]
Latest news
Recent market activity is centered on wider consumer access and portable testing rather than a single industry-defining transaction. In 2026, consumer providers were listing VO₂ max tests from $145 to $299, while market forecasts continued to identify portable and wearable metabolic systems as a growth area.[9][3][6]

02 Ranking

Top 10 Companies in the Vo2 Max Testing Industry

The leading companies in the vo2 max testing industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

COSMED stands out for VO2 max testing systems because it supplies Quark CPET, Q-NRG MAX and K5 systems for VO2 max testing, while PNOĒ focuses on lab-grade cardio-metabolic analyzers since it develops cardio-metabolic analyzers for VO2 max and metabolic testing.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in metabolic cart systems

    COSMED

    IT

    Ranked #1 · 8.9 · Metabolic cart systems

    Why we picked it: COSMED supplies Quark CPET, Q-NRG MAX and K5 systems for VO2 max testing.

  2. #2 overall

    PNOĒ

    US

    Ranked #2 · 8.8 · Metabolic cart systems

    Why we picked it: PNOĒ develops lab-grade cardio-metabolic analyzers for VO2 max and metabolic testing.

  3. #3 overall

    MGC Diagnostics

    US

    Ranked #3 · 8.6 · Metabolic cart systems

    Why we picked it: MGC Diagnostics develops metabolic testing systems under stress for cardiovascular and pulmonary performance.

Pick 1 is the #1 company overall. No other segment places in the top 5, so picks 2 and 3 follow rank.

Full ranking

Sort by
Top 10 companies in the vo2 max testing industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

COSMED

Metabolic cart systems · IT

8.9
2

PNOĒ

Metabolic cart systems · US

8.8
3

MGC Diagnostics

Metabolic cart systems · US

8.6
4

Jaeger Medical

Metabolic cart systems · DE

8.5
5

CORTEX Biophysik

Metabolic cart systems · DE

8.2
6

VO2 Master

Portable wearable VO2 analyzers · CA

8.1
7

Parvo Medics

Research and sports metabolic carts · US

8.0
8

KORR Medical Technologies

VO2 max systems for gyms and clinics · US

7.9
9

Geratherm Medical

Respiratory diagnostics and spiroergometry · DE

7.6
10

VacuMed

Metabolic carts and VO2 measurement systems · US

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the vo2 max testing industry. In Vo2 Max Testing Industry Statistics. Gitnux. https://gitnux.org/vo2-max-testing-industry-statistics/#top-companies

report visual · Comparison

Global metabolism testing market share by product type

Metabolic Carts holds the largest share at 43%.

Metabolic Carts43%
Body Composition Analyzers28.9%
ECG and EKG Systems17%
Breath Analyzers11%
source-verifiedpmarketresearch.com

04 Statistics

Pricing

Pricing stays segmented across public facilities and academic programs, with $165 per VO2max test in 2026 and $299 for a two-hour UCSF appointment.

Fees and price levels in the vo2 max testing industry

  • $165 per VO2max test is listed by George Washington University’s Metabolism and Exercise Testing Laboratory Core for public testing in Washington, D.C., in 2026.[1]
  • $360 per VO2max cardiorespiratory fitness test is listed in Mount Sinai Physiolab’s 2026 procedure rates for New York, United States.[2]
  • $299 per VO2 max assessment is listed by the UCSF Human Performance Center for a two-hour appointment in San Francisco, California, in 2026.[3]

Key questions about the vo2 max testing industry

What is the 2026 market size for VO2 max testing using the CPET proxy?
The global cardiopulmonary exercise testing market is estimated at $1.63 billion in 2026.
How fast is the VO2 max testing proxy market expected to grow from 2026 to 2031?
It is projected to reach $2.71 billion by 2031, implying a 10.74% CAGR from 2026 to 2031.
Which companies lead the vo2 max testing industry?
COSMED stands out for VO2 max testing systems because it supplies Quark CPET, Q-NRG MAX and K5 systems for VO2 max testing, while PNOĒ focuses on lab-grade cardio-metabolic analyzers since it develops cardio-metabolic analyzers for VO2 max and metabolic testing.
What technology direction is showing up in 2026 market activity?
Recent activity centers on wider consumer access and portable testing rather than a single industry-defining transaction, with portable and wearable metabolic systems identified as a growth area.
How is the market structured by end user and product in 2025?
Hospitals account for 53.41% of end-user revenue, CPET systems held 42.37% of product revenue, and clinical diagnostics represented 43.68% of application revenue.
What does U.S. clinical CPET billing cover under CPT 94621?
CPT 94621 covers cardiopulmonary exercise testing with minute ventilation, carbon-dioxide production, oxygen uptake and electrocardiographic recordings.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Vo2 Max Testing Industry Statistics. Gitnux. https://gitnux.org/vo2-max-testing-industry-statistics
MLA
Samuel Norberg. "Vo2 Max Testing Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/vo2-max-testing-industry-statistics.
Chicago
Samuel Norberg. 2026. "Vo2 Max Testing Industry Statistics." Gitnux. https://gitnux.org/vo2-max-testing-industry-statistics.